Similar articles

• The cautionary tale of PSA testing.

  Hoffman RM, Zeliadt SB. Hoffman RM, et al. Arch Intern Med. 2010 Jul 26;170(14):1262-3. doi: 10.1001/archinternmed.2010.222. Arch Intern Med. 2010. PMID: 20660847 No abstract available.
• Efficacy vs effectiveness in prostate-specific antigen screening.

  Albertsen PC. Albertsen PC. J Natl Cancer Inst. 2010 Mar 3;102(5):288-9. doi: 10.1093/jnci/djq002. Epub 2010 Feb 8. J Natl Cancer Inst. 2010. PMID: 20142583 No abstract available.
• PSA screening: the bottom line.

  Elhilali MM. Elhilali MM. CMAJ. 2000 Mar 21;162(6):791-2. CMAJ. 2000. PMID: 10750466 Free PMC article. No abstract available.
• [The PSA test does not hold for screening. Good--but not good enough].

  Holmström B, Johansson M, Bratt O, Stattin P. Holmström B, et al. Lakartidningen. 2010 Feb 17-23;107(7):436, 438-9. Lakartidningen. 2010. PMID: 20384076 Review. Swedish. No abstract available.
• [The significance and limitation of prostate specific antigen in the mass screening for prostate cancer].

  Imai K, Yamanaka H. Imai K, et al. Nihon Rinsho. 1998 Aug;56(8):1994-7. Nihon Rinsho. 1998. PMID: 9750494 Review. Japanese.